177 related articles for article (PubMed ID: 16550014)
1. Scintigraphic visualization of an epigastric sentinel node in recurrent breast cancer after lumpectomy and postoperative radiation therapy.
Milardovic R; Castellon I; Mills C; Altinyay ME; Raphael B; Abdel-Dayem HM
Clin Nucl Med; 2006 Apr; 31(4):207-8. PubMed ID: 16550014
[TBL] [Abstract][Full Text] [Related]
2. Contralateral uptake and metastases in sentinel lymph node mapping for recurrent breast cancer.
Agarwal A; Heron DE; Sumkin J; Falk J
J Surg Oncol; 2005 Oct; 92(1):4-8. PubMed ID: 16180213
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node surgery in locally recurrent breast cancer.
Boughey JC; Ross MI; Babiera GV; Bedrosian I; Feig BW; Hwang RF; Kuerer HM; Hunt KK
Clin Breast Cancer; 2006 Aug; 7(3):248-53. PubMed ID: 16942642
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy.
Taback B; Nguyen P; Hansen N; Edwards GK; Conway K; Giuliano AE
Ann Surg Oncol; 2006 Aug; 13(8):1099-104. PubMed ID: 16791446
[TBL] [Abstract][Full Text] [Related]
5. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
6. Altered lymphatic drainage after breast-conserving surgery and axillary node dissection: local recurrence with contralateral intramammary nodal metastases.
Wellner R; Dave J; Kim U; Menes TS
Clin Breast Cancer; 2007 Feb; 7(6):486-8. PubMed ID: 17386126
[TBL] [Abstract][Full Text] [Related]
7. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
8. Alternative lymphatic pathway after previous axillary node dissection in recurrent/primary breast cancer.
Sood A; Youssef IM; Heiba SI; El-Zeftawy H; Axelrod D; Seigel B; Mills C; Abdel-Dayem HM
Clin Nucl Med; 2004 Nov; 29(11):698-702. PubMed ID: 15483481
[TBL] [Abstract][Full Text] [Related]
9. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
10. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
11. Experience of sentinel node biopsy alone in early breast cancer without further axillary dissection in patients with negative sentinel node.
Soni NK; Spillane AJ
ANZ J Surg; 2005 May; 75(5):292-9. PubMed ID: 15932439
[TBL] [Abstract][Full Text] [Related]
12. The feasibility of sentinel node biopsy in the previously treated breast.
Koizumi M; Koyama M; Tada K; Nishimura S; Miyagi Y; Makita M; Yoshimoto M; Iwase T; Horii R; Akiyama F; Saga T
Eur J Surg Oncol; 2008 Apr; 34(4):365-8. PubMed ID: 17532172
[TBL] [Abstract][Full Text] [Related]
13. [Sentinel lymph node (SLN) in breast cancer: prediction of axillary metastasis confined to the SLN spares patients further axillary dissection].
Sato K; Hiraide H; Mochizuki H
Nihon Geka Gakkai Zasshi; 2001 Jun; 102(6):445-8. PubMed ID: 11436505
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node identification in breast cancer patients.
Fonti R; Limite G; Sodano A; Riccardi A; Forestieri P; De Cristofaro G; Pettinato G; Salvatore M
Radiol Med; 2002 Apr; 103(4):370-7. PubMed ID: 12107387
[TBL] [Abstract][Full Text] [Related]
16. Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection.
Setton J; Cody H; Tan L; Morrow M; Hudis C; Catalano J; McCormick B; Powell S; Ho A
Cancer; 2012 Apr; 118(8):1994-2003. PubMed ID: 21882186
[TBL] [Abstract][Full Text] [Related]
17. Non-axillary breast cancer recurrences after sentinel node biopsy.
van Rijk MC; Nieweg OE; Valdés Olmos RA; Rutgers EJ; Hoefnagel CA; Kroon BB
J Surg Oncol; 2005 Dec; 92(4):292-8. PubMed ID: 16299804
[TBL] [Abstract][Full Text] [Related]
18. Results of a standardized protocol for sentinel node imaging in breast cancer with Tc-99m labeled nanocolloidal albumin.
Rink T; Heuser T; Fitz H; Schroth HJ; Weller E; Zippel HH
Nuklearmedizin; 2001 Jun; 40(3):80-5. PubMed ID: 11475077
[TBL] [Abstract][Full Text] [Related]
19. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
Crossin JA; Johnson AC; Stewart PB; Turner WW
Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
[TBL] [Abstract][Full Text] [Related]
20. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
